Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferase
Release Time:2022-03-01 Hits:
Indexed by: Journal Article
Date of Publication: 2021-12-15
Journal: Toxicology and Applied Pharmacology
Volume: 424
Page Number: 115595-115603
Prev One:Cr (VI) induces crosstalk between apoptosis and autophagy through endoplasmic reticulum stress in A549 cells
Next One:Comparison of Hepatotoxicity Associated with New BCR-ABL Tyrosine Kinase Inhibitors vs Imatinib Among Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis